Adynamic bowel syndrome in Parkinson's disease with dramatic response to apomorphine

We report a parkinsonian patient who presented an adynamic bowel syndrome after l-dopa withdrawal during the course of a febrile illness. Due to lack of response to l-dopa attributable to gastrointestinal (G1) motility impairment, apomorphine treatment was started, and the adynamic bowel syndrome dr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Merello, M.
Otros Autores: Leiguarda, R.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1994
Acceso en línea:Registro en Scopus
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 02714caa a22006017a 4500
001 PAPER-19062
003 AR-BaUEN
005 20230518205025.0
008 190411s1994 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0028575724 
024 7 |2 cas  |a apomorphine, 314-19-2, 58-00-4; carbidopa plus levodopa, 57308-51-7; levodopa, 59-92-7; pergolide, 66104-22-1 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a CLNED 
100 1 |a Merello, M. 
245 1 0 |a Adynamic bowel syndrome in Parkinson's disease with dramatic response to apomorphine 
260 |c 1994 
270 1 0 |m Merello, M.Montaneses 2325, 1428 Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
520 3 |a We report a parkinsonian patient who presented an adynamic bowel syndrome after l-dopa withdrawal during the course of a febrile illness. Due to lack of response to l-dopa attributable to gastrointestinal (G1) motility impairment, apomorphine treatment was started, and the adynamic bowel syndrome dramatically improved. The use of apomorphine in Parkinson's disease patients with acute GI motility disorders is recommended.  |l eng 
593 |a Montaneses 2325, 1428 Buenos Aires, Argentina 
690 1 0 |a ADYNAMIC BOWEL SYNDROME 
690 1 0 |a APOMORPHINE 
690 1 0 |a MOTOR FLUCTUATIONS 
690 1 0 |a PARKINSON'S DISEASE 
690 1 0 |a APOMORPHINE 
690 1 0 |a CARBIDOPA PLUS LEVODOPA 
690 1 0 |a LEVODOPA 
690 1 0 |a PERGOLIDE 
690 1 0 |a ABDOMINAL RADIOGRAPHY 
690 1 0 |a AGED 
690 1 0 |a ARTICLE 
690 1 0 |a CASE REPORT 
690 1 0 |a CLINICAL FEATURE 
690 1 0 |a CLINICAL TRIAL 
690 1 0 |a CONSTIPATION 
690 1 0 |a DOSE RESPONSE 
690 1 0 |a DYSKINESIA 
690 1 0 |a GASTROINTESTINAL MOTILITY 
690 1 0 |a HUMAN 
690 1 0 |a INTRAVENOUS DRUG ADMINISTRATION 
690 1 0 |a MALE 
690 1 0 |a PARALYTIC ILEUS 
690 1 0 |a PARKINSON DISEASE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a SUBCUTANEOUS DRUG ADMINISTRATION 
700 1 |a Leiguarda, R. 
773 0 |d 1994  |g v. 17  |h pp. 574-577  |k n. 6  |p CLIN. NEUROPHARMACOL.  |x 03625664  |t Clinical Neuropharmacology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028575724&partnerID=40&md5=4527031462aff7d2bffd0966bca5bbc3  |y Registro en Scopus 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_03625664_v17_n6_p574_Merello  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03625664_v17_n6_p574_Merello  |y Registro en la Biblioteca Digital 
961 |a paper_03625664_v17_n6_p574_Merello  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 80015